AZN - Spark Newswire

2 minute read

AstraZeneca Announced Tagrisso Approved in EU in Early Lung Cancer

Today, 2:52 PM

AstraZeneca's (NYSE: AZN) Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after complete tumour resection with curative intent.

AZN

1 minute read

Uncategorized

India To Skip Local Trials for ‘Well Established’ COVID-19 Vaccines; Pfizer Shots May Arrive By July: Reuters

By Vandana Singh

Today, 2:52 PM

As a step to accelerate vaccination rollout, India has reportedly scrapped local trials for “well-established” foreign COVID-19 vaccines, with a…

AZN

2 minute read

Uncategorized

EU Seeks Fines For AstraZeneca Over COVID-19 Vaccine Delays: Reuters

By Vandana Singh

Today, 2:52 PM

The European Union took on AstraZeneca Plc (NASDAQ:AZN) in a Brussels court and accused it of diverting doses promised to the…

AZN

1 minute read

Uncategorized

Nipro To Provide Fill, Finish Services For AstraZeneca COVID-19 Shots In Japan: Reuters

By Vandana Singh

Today, 2:52 PM

Japan’s Nipro Corporation has signed an agreement to supply AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine in Japan, reports Reuters. Nipro said that the…

AZN

1 minute read

Uncategorized

Japan’s Nipro Corporation Announced Contract Manufacturing Agreement for Domestic Supply of AstraZeneca COVID-19 vaccine Vaxzevria Intramuscular Injection

By Charles Gross

Today, 2:52 PM

Nipro Corporation and our pharmaceutical manufacturing subsidiary Nipro Pharma Corporation hereby announces that we have entered into a Contract Manufacturing Agreement with AstraZeneca (NYSE: AZN) for the fill and finish process of AstraZeneca's COVID-19 vaccine, "Vaxzevria™ intramuscular injection".

AZN

1 minute read

Uncategorized

UK Competition Watchdog Probes AstraZeneca’s $39B Alexion Takeover

By Vandana Singh

Today, 2:52 PM

The U.K. competition regulator is mulling over AstraZeneca Plc’s (NASDAQ: AZN) $39 billion takeover taker of Alexion Pharmaceuticals Inc (NASDAQ: ALXN) over competition concern. The…

ALXN

1 minute read

Uncategorized

AstraZeneca Said CMA Review of Alexion Deal is Another Step Towards Closing the Deal, Expected in Q3

By Charles Gross

Today, 2:52 PM

-Reuters https://www.reuters.com/world/uk/britain-looking-into-astrazeneca-alexion-deal-competition-concerns-2021-05-25/

ALXN

2 minute read

Uncategorized

Pfizer Hits Deadlock With India Over Vaccine Indemnity Issue: Reuters

By Vandana Singh

Today, 2:52 PM

Pfizer Inc (NYSE: PFE) and the Indian government are at loggerheads over a demand by the company for legal protection from any claims linked to the use of its COVID-19 vaccine, said

AZN

1 minute read

Uncategorized

Japan Approves AstraZeneca’s COVID Vaccine, But Puts Use on Hold Amid Blood Clot Concern

By Vandana Singh

Today, 2:52 PM

Along with the approval of Moderna’s COVID-19 vaccine, Japan’s regulatory authority has also approved AstraZeneca Plc’s (NASDAQ: AZN) COVID-19 vaccine, Vaxzevria for…

AZN